Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Lloyds Banking Group Plc American Depositary Shares (LYG) vs Sana Biotechnology Inc (SANA) Price & Performance

Lloyds Banking Group Plc American Depositary SharesTrade
Sana Biotechnology IncTrade

Price performance (Past 24H)

Key statistics

Lloyds Banking Group Plc American Depositary Shares vs Sana Biotechnology Inc — how do they compare? Lloyds Banking Group Plc American Depositary Shares trades at $5.41 (market cap $76.34B), while Sana Biotechnology Inc trades at $2.8 (market cap $836.71M). The key difference: Lloyds Banking Group Plc American Depositary Shares is far larger — about 91.2× Sana Biotechnology Inc's market cap, and Lloyds Banking Group Plc American Depositary Shares pays a 4.05% dividend while Sana Biotechnology Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lloyds Banking Group Plc American Depositary Shares for 1 Days and Sana Biotechnology Inc for 23 Days on average.

LYGSANA
Market Cap
$76.34B$836.71M
Volume
16,671,7334,507,444
Sector
FinancialsHealth
52-Week High
$6.28$5.92
52-Week Low
$4.42$2.68
Typical Hold Time
1 Days23 Days
Enterprise Value
$99.66B$749.96M
Dividend Yield
4.05%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Lloyds Banking Group Plc American Depositary Shares

No Aura AI signal available yet.

Sana Biotechnology Inc

SANA Biotechnology trades at $2.84, up 4.41% today, while showing bearish technical signals with moving averages indicating selling pressure. The company remains pre-revenue with significant losses (-$244.17M net income in 2025) and negative cash flow from operations. Recent investor conference presentations highlight ongoing development of engineered cell therapies, though earnings have missed expectations in two of the last three quarters.

Despite analyst optimism (82% buy ratings), SANA faces substantial execution risk as a clinical-stage biotech with no current revenue and high cash burn. The stock's outlook depends heavily on clinical trial progress and future funding needs, with current valuation at 5.41x book value despite negative profitability metrics.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

LYG

No sentiment data available yet.

SANA
32% Buy68% Sell
Avg holding period · 23 Days

About Lloyds Banking Group Plc American Depositary Shares

Lloyds Banking Group provides retail, commercial, and insurance services in the United Kingdom. Its banking brands include Lloyds Bank, Halifax, and Bank of Scotland.

Read more on LYG →

About Sana Biotechnology Inc

Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.

Read more on SANA →